On December 12, 2011, the Company's Board of Directors expanded the size of the Board from 13 to 15 members. In addition, the Board of Directors elected Dr. Marc Tessier-Lavigne and Dr. Helen Hobbs to serve as members of the Board, effective immediately.
Tessier-Lavigne is president of Rockefeller University and the former head of drug discovery at Genentech.